These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6326558)

  • 1. Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.
    Woosley RL; Wang T; Stone W; Siddoway L; Thompson K; Duff HJ; Cerskus I; Roden D
    Am Heart J; 1984 May; 107(5 Pt 2):1058-65. PubMed ID: 6326558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Monk JP; Brogden RN
    Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mexiletine: pharmacology and therapeutic use.
    Manolis AS; Deering TF; Cameron J; Estes NA
    Clin Cardiol; 1990 May; 13(5):349-59. PubMed ID: 2189614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
    J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine: a new type I antiarrhythmic agent.
    Schrader BJ; Bauman JL
    Drug Intell Clin Pharm; 1986 Apr; 20(4):255-60. PubMed ID: 2421992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 13. Mexiletine: a new antiarrhythmic drug.
    Leahey EB; Bigger JT
    Ann Intern Med; 1980 Mar; 92(3):427-9. PubMed ID: 6986832
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    Eur J Clin Pharmacol; 1983; 25(6):773-7. PubMed ID: 6662176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman AC; Dunning AJ
    Br Heart J; 1976 Dec; 38(12):1262-71. PubMed ID: 1008969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
    Burke GH; Loukides JE; Berman ND
    J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle.
    Courtney KR
    Eur J Pharmacol; 1981 Aug; 74(1):9-18. PubMed ID: 6274652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.